Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I, Single Blind, Placebo-controlled, Randomized Study to Assess the Safety of DS-1040b in Subjects With Thrombectomy Treated Acute Ischemic Stroke.

NCT03198715 is registered in ClinicalTrials.gov with Daiichi Sankyo Co., Ltd. as lead sponsor.

NCT NCT03198715
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03198715 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I, Single Blind, Placebo-controlled, Randomized Study to Assess the Safety of DS-1040b in Subjects With Thrombectomy Treated Acute Ischemic Stroke.
Lead sponsor
Daiichi Sankyo Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
July 30, 2017
Completion date
January 19, 2020
Enrollment
42 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke